FORTE BIOSCIENCES INC (FBRX) Stock Income Statement
NASDAQ:FBRX - Nasdaq - US34962G2084 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 45.10M | 37.00M | 32.00M | 13.90M | 21.49M | |||
| Research and Development | 29.53M | N/A | 21.86M | 5.59M | 13.85M | |||
| Selling, General, and Administrative Expenses | 15.39M | 15.00M | 11.00M | 8.30M | 7.63M | |||
| Operating Income | -45.10M | -37.00M | -32.00M | -13.90M | -21.49M | |||
| Interest Income/Expense | N/A | N/A | 1.12M | N/A | N/A | |||
| Other Income/Expense | -103.00K | 2.00M | -110.00K | 20.00K | -220.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -44.20M | -35.00M | -31.00M | -13.88M | -21.71M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -44.20M | -35.00M | -31.00M | -13.88M | -21.71M | |||
| EBITDA | -45.06M | -36.96M | -31.99M | N/A | -21.45M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -14.10 | -12.00 | -24.60 | -0.80 | -1.55 | |||
| Non GAAP EPS | -15.11 | -17.74 | N/A | N/A | -38.50 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD